Skip to main content
. 2017 Dec 27;61(4):405–410. doi: 10.1515/jvetres-2017-0062

Table 4.

IgG contents (g/L) in blood sera of each group

Groups Ingredient concentration Drug control PCV2 control Blank control
10 mg/kg 5 mg/kg 1 mg/kg 10 mg/kg 105TCID50 -
SSA 5.8 ± 0.23* 5.35 ± 0.73 5.02 ± 0.28 4.81 ± 0.47    
SSD 5.86 ± 0.28* 5.6 ± 0.57 5.23 ± 0.29 4.96 ± 0.27    
PNS 5.53 ± 0.72 5.12 ± 0.48 4.70 ± 0.57 4.54 ± 0.48 4.92 ± 0.35 4.18 ± 0.38
SR1 5.34 ± 0.78 5.23 ± 0.61 4.57 ± 0.29 4.68 ± 0.41    
AB4 5.76 ± 0.4* 5.39 ± 0.67 4.88 ± 0.69 4.64 ± 0.51    

Data shown are mean (± SD) g/L

Value significantly different from PCV2 control group at * P < 0.05